# OnCo record paper-gpc3-hcc-oncoimmunology-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gpc3-hcc-oncoimmunology-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gpc3-hcc-oncoimmunology-2016" ;
  schema:name "Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients"@en ;
  schema:description "Phase 2 or 3 results paper on GPC3 in Hepatocellular carcinoma, in Oncoimmunology (2016), one of the most cited Europe PMC records with GPC3 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-gpc3-hcc-oncoimmunology-2016/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1080/2162402x.2015.1129483>, <https://pubmed.ncbi.nlm.nih.gov/27467945/>, <https://europepmc.org/article/MED/27467945> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1080/2162402x.2015.1129483> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Sawada Y, Yoshikawa T, Ofuji K, et al." ;
  onco:journals <https://onco.cc/journals/oncoimmunology/> .